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The liver is thought to utilize facultative stem cells,
also known as ‘‘oval cells’’ or ‘‘atypical ductal cells’’
(ADCs), for regeneration following various types
of injury. However, this notion has been based largely
on in vitro studies and transplantation models;
where lineage tracing has been used, results have
been conflicting and effect sizes have been small.
Here, we used genetic and nucleoside analog-based
tools to mark and track the origin and contribution of
various cell populations to liver regeneration in vivo
following several ADC-inducing insults. We report
that, contrary to prevailing stem-cell-based models
of regeneration, virtually all new hepatocytes come
from preexisting hepatocytes.
INTRODUCTION
It is well established that organs can maintain homeostasis via
either cellular replication or differentiation from stem cells. In
addition, it has been proposed that select tissues contain a pop-
ulation of so-called ‘‘facultative stem cells,’’ which contribute to
tissue homeostasis under special circumstances. By definition,
facultative stem cells lack stem cell activity during normal tissue
turnover but are recruited during specific types of injury to func-
tion as stem or progenitor cells (Yanger and Stanger, 2011). The
mammalian liver has stood as the major paradigm for regenera-
tion via a facultative stem-cell-mediated recovery. In response
to various disease states and toxin-induced injuries, rodents
and humans exhibit an accumulation of atypical ductal cells
(ADCs)—commonly referred to as ‘‘oval cells’’—within the liver
parenchyma (Farber, 1956; Popper et al., 1957). ADCs have a
ductal morphology, but their arrangement into an intricate anas-
tomosing configuration that extends into the hepatic lobule gives340 Cell Stem Cell 15, 340–349, September 4, 2014 ª2014 Elsevier Ithem a histologic appearance that is distinct from that of normal
biliary epithelial cells (BECs) (Desmet, 1985). ADCs are thought
to arise from BECs within the Canals of Hering, structures
that reside at the interface of the intrahepatic bile ducts and
hepatocyte-lined canaliculi (Figure 1A) (Factor et al., 1994; Prei-
segger et al., 1999). This putative mode of recovery stands in
contrast to liver regeneration following surgical resection, which
is mediated largely through cell growth and division (Miyaoka
et al., 2012).
Based on in vitro studies, ultrastructural analyses, and cell
transplantation assays, ADCs have been proposed to function
as bipotent facultative stem cells, giving rise to both hepatocytes
and BECs, during toxin-mediated liver injury, although this issue
is controversial (Espan˜ol-Sun˜er et al., 2012; Fausto and Camp-
bell, 2003; Friedman and Kaestner, 2011; Furuyama et al.,
2011; Huch et al., 2013; Malato et al., 2011; Zaret and Grompe,
2008). Furthermore, adult hepatocytes exhibit significant plas-
ticity in vivo, a phenomenon that may give the appearance of
stem-cell-mediated differentiation (Michalopoulos et al., 2005;
Tanimizu et al., 2014; Yanger et al., 2013). In order to obtain
direct evidence for liver stem cell activity in vivo, we labeled three
distinctive cell populations in the liver —BECs, hepatocytes, and
rapidly dividing cells—using both direct genetic and unbiased
nucleoside analog-based lineage labeling tools under multiple
ADC-inducing injury conditions. Our studies demonstrate
that hepatocytes, not ADCs, serve as the major, if not exclusive,
source for hepatocyte renewal and regeneration in the adult liver,
regardless of the type of injury.
RESULTS
BECs Do Not Exhibit Progenitor Cell Activity In Vivo
BECs residing within the Canals of Hering are thought to serve
as precursors of liver progenitor cells (Factor et al., 1994; Wang
et al., 2003). Such BECs, in both rodent and human studies,
are characterized as single or small groups of cells positive
for the BEC marker, cytokeratin-19 (KRT19), and located withinnc.
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ford et al., 1998; Roskams et al., 2004; Saxena and Theise,
2004; Theise et al., 1999). To directly address the ability of
these cells to differentiate into hepatocytes in vivo, we crossed
inducible KRT19 promoter (Krt19) CreER knockin mice (Means
et al., 2008) to Rosa26YFP reporter mice (Srinivas et al., 2001) to
label cells from the BEC lineage prior to injury (Figure 1A).
Bigenic Krt19-CreER/R26YFP mice were given tamoxifen, result-
ing in pulse labeling completely restricted to BECs as pre-
viously reported, with no yellow-fluorescent-protein-positive
(YFP+) cells staining for the hepatocyte marker hepatocyte
nuclear factor 4 a (HNF4a) (Figure 1B, top panel; Scholten
et al., 2010). The efficiency of labeling was 36.2% ± 8.7%
of Krt19+ cells (Figure 1B, middle panel; n = 4) and included
single/small groups of cells within the Canals of Hering (Fig-
ure 1B, bottom panels).
To ensure that labeling was not limited to a specific subset of
BECs, we examined the expression of TROP2, a widely used
oval cell/ADC marker (Okabe et al., 2009; Yamazaki et al.,
2011), and found that Krt19+/YFP+ cells and Krt19+/YFP cells
stained positively for TROP2 with equal frequency (Figures
S1A and S1B available online). We further assessed the spec-
trum of cellular labeling by costaining with YFP and a number
of other BEC/ADC markers. This analysis showed that colabel-
ing occurred with a similar efficiency to that observed with
Krt19, as 39.5% of Sox9+ cells (n = 3), 31.6% of osteopontin+
(Opn+) cells (n = 3), and 40.8% of HNF1b+ cells (n = 3) were
labeled (Figure 1C). Considering that Krt19 staining overlaps
completely with staining for these BEC markers (353/353
Sox9+ cells, n = 3; 352/352 OPN+ cells, n = 3; and 349/349
HNF1b+ cells, n = 2), these results suggest that tamoxifen
treatment of Krt19-CreER/R26YFP mice results in specific label-
ing of BECs, including the putative progenitor cells that reside
within the Canals of Hering.
We then tested whether labeled BECs give rise to hepatocytes
under injury or homeostatic conditions. Six- to eight-week-old
bigenic mice were given tamoxifen and, after a washout period
of two weeks, were subjected to an injury-recovery protocol
with various ADC-inducing injury models including 3,5-di-
ethoxycarbonyl-1,4-dihydrocollidine (DDC); a choline-deficient
ethionine-supplemented (CDE) diet; CCl4 administration; and
alpha-naphthyl-isothiocyanate (ANIT) diet. Under all injury-re-
covery circumstances, all YFP+ cells costained for the biliary
marker Krt19 but not the hepatocyte marker HNF4a (Figure 1D)
(DDC: 1,191 cells counted, n = 3; CDE: 1,157 counted, n = 3;
for ANIT and CCl4, data not shown). Thus, any contribution of
YFP+ BECs to hepatocytes during regeneration from these
injuries was below the limit of detection.
To determine whether BECs might generate hepatocytes over
longer periods of time, as has been previously reported for Sox9+
BECs (Furuyama et al., 2011), we examined Krt19-CreER/
R26YFP mice 9 months after tamoxifen labeling. Following this
long ‘‘chase’’ period, all YFP+ cells continued to stain for biliary
markers but not hepatocytemarkers (Figure 1E; 1,154 YFP+ cells
examined for biliary markers, 4,773 YFP+ cells examined for
hepatocyte markers). Likewise, no YFP+ cells exhibited morpho-
logical features of hepatocytes. Hence, KRT19-expressing BECs
do not appear to give rise to hepatocytes following injury or
during normal liver turnover.Cell SADCs Do Not Exhibit Progenitor Cell Activity In Vivo
It is possible that KRT19+ADCs arise from a unique cell popula-
tion that is not labeled in the quiescent state. To this end, we
administered tamoxifen to Krt19-CreER/R26YFP mice during
the second half of treatment with ADC-inducing injuries including
DDC and CDE, thus labeling newly formed ADCs (Figure 2A).
Injury alone (in the absence of tamoxifen) did not induce recom-
bination of the reporter allele (Figure 2B). Tamoxifen administra-
tion resulted in YFP labeling of KRT19+ cells during DDC and
CDE injuries (pulse; n = 3; Figures 2C and 3D, top panels),
including A6+ ADCs (Figure S2A). The labeling encompassed
cells within large Krt19+ mature-appearing ductal structures,
as well as isolated ductal cells that penetrated the lobule,
including Sox9+ cells (pulse; Figures 2C and 2D, middle panels).
Labeling during the injury was highly specific for ADCs, as all
labeled cells (DDC: 1,010 counted, n = 6; CDE: 3,904 counted,
n = 2) exhibited a biliarymorphology and stainedwith ADC/biliary
markers but lacked a hepatocyte morphology and were negative
for HNF4a (pulse; Figures 2C and 2D, bottom panels).
Following 2–3 weeks of recovery (Chase), YFP+ cells were
readily detected in the livers of Krt19-CreER/R26YFP mice.
YFP+ cells in the recovery group resembled normal BECs,
exhibiting a biliary morphology and staining with biliary markers
(chase; Figures 2C and 2D, top and middle panels). Consistent
with our results from BEC labeling prior to injury, YFP expression
was never observed in cells with a hepatocyte morphology or
HNF4a expression (chase; Figures 2C and 2D, bottom panels;
DDC: 2,474 counted, n = 5; CDE: 4,252 counted, n = 4). As
some stem/progenitor cell populations undergo replication rates
that differ from those of surrounding cells (Blanpain et al., 2007),
we ensured there was equal YFP labeling of proliferating and
nonproliferating ADCs using Ki-67 (Figure S2B). These results
indicate that ADCs labeled under multiple-injury conditions do
not give rise to hepatocytes. Taken together, the results reveal
that neither ADCs nor BECs (their presumptive cells of origin)
give rise to hepatocytes under homeostatic conditions or after
toxin-mediated injury.
Hepatocytes Are Derived from Preexisting Hepatocytes
In Vivo
These experiments do not rule out the possibility that hepato-
cytes arise from progenitor cells that were not marked by the
Krt19-CreER labeling approach (including ‘‘marker-negative’’
cells). To test this possibility, we labeled differentiated hepato-
cytes and determined the contribution of ‘‘nonhepatocytes’’
to recovery following injury (Figure 3A). The rationale for the
approach follows from the expectation that unlabeled stem cells
contributing to liver regeneration would give rise to unlabeled
progeny, resulting in decreased hepatocyte-labeling index (Fig-
ure 3Bi). Alternatively, if new hepatocytes are derived solely
from existing hepatocytes, then the hepatocyte-labeling index
would remain unchanged (Figure 3Bii). This method has been
used as a general means of determining the degree to which
putative stem/progenitor cells contribute to tissue regeneration
when markers of such cells are lacking (Dor et al., 2004).
To label hepatocytes—defined here as postnatal cells ex-
pressing HNF4a but not expressing BEC markers—we utilized
a replication-incompetent, recombinant adeno-associated virus
serotype 2/8 expressing Cre recombinase driven by thetem Cell 15, 340–349, September 4, 2014 ª2014 Elsevier Inc. 341
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Figure 1. BECs Lack Detectable Progenitor Cell Activity In Vivo
(A) Schematic view of BEC labeling usingKrt19-CreER;R26YFPmice. An idealized hexagonally shaped lobule is shown. A blow-up of one portal tract illustrates the
interface between BECs (blue) and hepatocytes (crimson). Cells aremarked in amosaic fashion on tamoxifen injection (‘‘Pulse’’), and the ability of labeled BECs to
give rise to hepatocytes is assessed following injury and recovery or under long-term (9 month) homeostatic conditions (‘‘Chase’’).
(B) YFP-labeling at ‘‘pulse.’’ Labeling occurs exclusively in BECs that are negative for HNF4a (top panel) and positive for Krt19 in ducts (middle panel) or within the
Canals of Hering (bottom panels).
(C) Costaining of the YFP label with the BEC markers Sox9, OPN, and HNF1b (arrowheads mark double positive/triple cells).
(legend continued on next page)
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Liver Regeneration Does Not Utilize Stem Cellshepatocyte-specific promoter (thyroid hormone-binding glob-
ulin, AAV8-TBG-Cre). One of the reasons for using this method
is that the tamoxifen used to induce recombination in Cre-based
inducible models has been shown to have a ‘‘toxin-like’’ effect,
leading to ectopic activation of BEC genes in hepatocytes
such as Sox9 (Carpentier et al., 2011). We thus wanted to
circumvent this potential mislabeling by using the AAV8-TBG-
Cre instead to label hepatocytes. This transduction was highly
specific, as all YFP+ cells were HNF4a+ as previously shown
(Wang et al., 2010; Yanger et al., 2013). Moreover, labeling
was efficient, as more than 99% of hepatocytes were genetically
marked when R26YFP mice were infected (Figures 3C–3E), with
no labeling of nonhepatocytes (Yanger et al., 2013). We have
previously shown that the AAV8 serotype provides a hepato-
cyte-specific tropism within the liver, as only hepatocytes are
labeled by infection with viruses carrying Cre recombinase under
the control of a ubiquitously expressed cytomegalovirus pro-
moter (Yanger et al., 2013). Thus, AAV8-TBG-Cre permits label-
ing in the liver that is highly efficient and specific for hepatocytes.
We then subjected lineage-labeled AAV8-TBG-Cre; R26YFP
mice (pulse) to the injury-recovery protocols described earlier
(chase). Under these conditions, the percentage of labeled he-
patocytes remained unchanged (Figures 3D and 3E). Specif-
ically, the labeling index for the pulse group (99.36% ± 0.96%,
11,359 counted) did not decrease following recovery after DDC
(99.31% ± 1.00%, 5,830 counted), CDE (99.83% ± 0.17%,
1,838 counted), CCl4 (99.75% ± 0.38%, 1,677 counted), or
ANIT (100%, 1,944 counted). As a control, we performed 2/3
partial hepatectomy, which also showed no change in the YFP
labeling index (99.71% ± 0.36%, 695 counted). Thus, by this
sensitive labeling technique, we failed to find evidence that
hepatocytes arise from nonhepatocytes after recovery frommul-
tiple types of ADC-inducing injuries.
Previous studies have shown that the AAV8 viral genome is
cleared from the body within days of infection (Zincarelli et al.,
2008). However, we sought to further confirm that new, unla-
beled hepatocytes were not transduced and labeled by potential
AAV8 persistence in the system. To this end, we performed a
serum transfer experiment in which we assessed the infective
activity of the virus by isolating serum from mice given AAV8 2
or 30 weeks previously and injecting it into Cre-naive R26YFP
mice. Livers of these serum-recipient mice were assessed 1 or
6 weeks later, and no YFP signal was detected (Figure 4; data
not shown). These results indicate that the durability of high
(>99%) levels of hepatocyte labeling after the injury-recovery
period is not due to labeling of progenitor-derived hepatocytes
that are infected by latent AAV8 viral particles.
Rapidly Proliferating Cells in the Liver Do Not Give Rise
to Hepatocytes
Finally, we complemented the two genetic lineage tracing
methods with an unbiased labeling approach that marks rapidly
cycling cells during injury and identifies their progeny. Stem cells(D) Following injury-recovery, a similar pattern and degree of labeling is observe
and CDE).
(E) Livers from Krt19-CreER; R26YFPmice examined 9 months after tamoxifen injec
Images shown are representative of multiple experiments (pulse: n = 7; DDC: n =
TM, tamoxifen; CV, central vein; PV, portal vein; HA, hepatic artery. White scale
Cell Scontribute to tissue homeostasis and regeneration by generating
rapidly dividing progeny—commonly referred to as transit-
amplifying (TA) cells—which expand prior to final differentiation
(Blanpain et al., 2007). ADCs with their high proliferative
index are characterized as liver TA cells (Alison et al., 2004).
Teta et al. have previously reported that TA cells can be labeled
by incorporation of two thymidine analogs (i.e., dual labeling)
when administered in succession (Teta et al., 2007).
We first showed that we could track double-labeled progenitor
cells using the thymidine analogs iododeoxyuridine (IdU) and
chlorodeoxyuridine (CldU) in the intestine (Figures S3A and
S3B) and verified long-term stability of the label in the liver (Fig-
ure S3C). We next applied this labeling method to livers sub-
jected to injury induced by CDE diet and DDC treatment, as
these injuries have been reported to promote ‘‘liver progenitor
cell’’ activity (Bird et al., 2008; Wang et al., 2003). Administration
of IdU and CldU resulted in the labeling of both hepatocytes and
ADCs in CDE-treated mice, with a significant number of ADCs
exhibiting dual labeling (Figure 5A). We treated this dual labeling
as a pulse condition for lineage tracing, reasoning that if new he-
patocytes are derived from rapidly cycling, then the frequency of
double-labeled hepatocytes should be higher in the chase sam-
ples than in the pulse samples (Figure 5Bi). By contrast, if new
hepatocytes are derived by self-duplication, the frequency of
double-labeled hepatocytes should not increase (Figure 5Bii).
For this protocol, mice received the CDE diet followed by IdU
and CldU administration (Figure 5B), with adequate washout be-
tween the two thymidine analogs to avoid overlap (Figure S3D).
Postlabeling, a liver biopsy (3% of liver mass) was obtained in
order to quantify labeling indices for each animal (pulse). This
minimal hepatectomy did not result in any measurable compen-
satory proliferation and was representative of the rest of the liver
(Figure S3E). After a 4-week chase period, mice were sacrificed,
and the number of single- and double-labeled hepatocytes and
BECs in the pulse and chase groups were compared. As the
response to CDE is heterogeneous, we included in the analysis
only mice that exhibited negligible dual labeling of hepatocytes
in the pulse biopsy (<4% of hepatocytes, n = 6).
Examination of the pulse biopsy revealed that 7.0% ± 6.5% of
cycling ADCs were double labeled during CDE treatment,
compared to 1.3% ± 1.4% of cycling hepatocytes (Figure 5C).
We also detected double-labeled cells that were neither hepato-
cytes nor BECs, indicating that rapidly cycling cells exist in other
liver populations (e.g., inflammatory or endothelial cells). At the
chase, we observed a similar percentage of double-labeled
ADCs (11% ± 8%), with no increase in the percentage of
double-labeled hepatocytes (0.8% ± 0.9%; Figure 5C). Further
experiments, in which a 4-week injury-free recovery period
was used, yielded the same conclusion (Figure S3F).
To ensure that our failure to observe a contribution of rapidly
proliferating cells to hepatocytes was not specific to the CDE
injury model, we performed a similar experiment in DDC-treated
mice. Dual nucleoside analog administration in the setting ofd after the chase; no YFP label is observed in hepatocytes (‘‘Chase’’ – DDC
tion do not show any hepatocytes bearing the YFP label (‘‘Chase’’ – 9 months).
8; CDE: n = 3; 9 months chase group: n = 5).
bars, 50 mm, yellow scale bar, 5 mm. See also Figure S1.
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Figure 2. ADCs Do Not Give Rise to Hepatocytes
(A) Schematic view of ADC labeling using Krt19-CreER;R26YFPmice. Treatment of mice with toxin (Injury) leads to the emergence of ADCs in the lobule (blue cells
mingled with hepatocytes). Lineage labeling (‘‘Pulse’’) results in the heritable marking of ADCs (green) but not hepatocytes; labeled progeny can be followed after
recovery (‘‘Chase’’).
(B) DDC-treated Krt19-CreER;R26YFP mice do not exhibit YFP expression in the absence of tamoxifen.
(C) The Krt19-CreER transgene permits specific labeling of Krt19+ and Sox9+ ADCs after DDC treatment. No label-bearing hepatocytes were observed during the
pulse (‘‘Pulse’’) or following recovery (‘‘Chase’’).
(D) The Krt19-CreER transgene permits specific labeling of KRT19+ and Sox9+ ADCs after CDE treatment. No label-bearing hepatocytes were observed during
the pulse (‘‘Pulse’’) or following recovery (‘‘Chase’’). Scale bar, 50 mm.
See also Figure S2.
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Figure 3. A Pulse-Chase System for Deter-
mining the Origin of Regenerating Hepa-
tocytes
(A) Schematic view of hepatocyte labeling using
AAV8-based lineage tracing. Labeling via viral
infection (‘‘Pulse’’) results in the heritable marking
of hepatocytes (green), but not BECs.
(B) Predictions from different models of liver
regeneration. After injury and recovery (‘‘Chase’’),
stem-cell-based repair would result in a decrease
in the hepatocyte labeling index (i), while hepato-
cyte-mediated recovery would result in no change
in labeling index (ii).
(C) Hepatocyte labeling was achieved by admin-
istering AAV8-TBG-Cre to R26YFP mice; immuno-
fluorescent images show specific and efficient
labeling of hepatocytes. Labeling of BECs was
never observed following AAV (lower panel, n = 6).
(D) Liver histology returns to normal following
injuries with DDC, CDE, CCl4, ANIT, and partial
hepatectomy (PHx) (H&E, hematoxylin and eosin,
left panels), with no appreciable change in the
frequency of hepatocyte labeling. Scale bar,
50 mm.
(E) Quantification of hepatocyte labeling following
AAV injection (‘‘Pulse’’) and recovery from DDC,
CDE, CCl4, ANIT, and PHx injuries. Labeling index
was quantified from six, six, four, four, two, and
two mice for each of the conditions, respectively
(means ± SD). Absolute numbers of cells counted
for pulse and chase are provided in Results.
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Liver Regeneration Does Not Utilize Stem CellsDDC injury resulted in double labeling of 4.2% ± 1.7% of cycling
ADCs and 13.4% ± 1.1% (n = 7) of cycling hepatocytes (Fig-
ure 5D). After a chase period of 4weeks postinjury, the frequency
of double-labeled hepatocytes had decreased (6.0% ± 1.6%,
p < 0.001, n = 7; Figure 5D), and there was no change in the fre-
quency of double-labeled ADCs (3.3% ± 2.4%; Figure 5D). Thus,
these analyses suggest that there is no significant contribution of
rapidly proliferating cells—either ADCs or other types of rapidly
dividing cells—to the hepatocyte pool following CDE- or DDC-
mediated liver damage.
DISCUSSION
In this study, we have used three distinct lineage tracing ap-
proaches to test the hypothesis that regeneration from toxin-
induced liver damage is mediated by facultative stem cells. First,
we genetically labeled KRT19-expressing BECs and ADCs—Cell Stem Cell 15, 340–349, Sthe tissue compartment in which liver
stem cells are believed to reside—and
found no evidence that these cells give
rise to hepatocytes in the four injury
models tested. Second, we labeled hepa-
tocyteswith highefficiencyandspecificity
and found that there was no decrease in
the labeling index with the same types
of injury, a result that is consistent with
the notion that new hepatocytes are
derived from preexisting hepatocytes.
Finally, we used nucleoside analog label-ing to trace the fate of highly proliferative liver cells, finding no
evidence that rapidly dividing nonhepatocytes differentiated
into hepatocytes. Taken together, these data suggest that
ADCs and other nonhepatocyte populations do not contribute
significantly to hepatocyte neogenesis during liver regeneration.
The long-standing notion that ADCs are facultative stem cells
has been based largely on static observations, in vitro studies,
and cellular transplantation assays (Huch et al., 2013; Shin
et al., 2011; Wang et al., 2003). However, these assays test
cell potential rather than cell fate. Previous work from our lab
and others have demonstrated significant plasticity between
hepatocytes and BECs, both in vitro and in vivo (Limaye et al.,
2008b; Michalopoulos et al., 2005; Nishikawa et al., 2005; Tani-
mizu et al., 2014; Yanger et al., 2013). Thus, while cell transplan-
tation and in vitro culture can provide insight into cell potential
under these experimental conditions, lineage tracing permits a
more accurate indication of cell fate.eptember 4, 2014 ª2014 Elsevier Inc. 345
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Figure 4. NewHepatocytes Are Not Labeled
on AAV Serum Transfusion
(A) Schematic showing the timing of infection,
serum transfer, and analysis of injected R26YFP
mice; each red ‘‘x’’ indicates a sampling point.
AAV8-TBG-Cre-injected mice were analyzed
either 2 weeks (‘‘Pulse’’) or >30 weeks after injec-
tion (Long-term ‘‘chase’’). Prior to analysis at
2 weeks, mice were bled, and serum was in-
jected into naive, uninfected R26YFP mice whose
livers were assessed after 1 week (Recipient).
Uninfected mice served as a control (Uninjected).
(B) Images showing immunoflurescence staining
for YFP (green) and Krt19 or HNF4a (red) in livers
from each of the four groups analyzed.
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Liver Regeneration Does Not Utilize Stem CellsSeveral groups have used lineage tracing to characterize the
origin and fate of ADCs. Initial work using [3H]-thymidine incor-
poration gave rise to discordant conclusions, with experimental
evidence both favoring (Evarts et al., 1987, 1989) and refuting
(Grisham and Porta, 1964; Tatematsu et al., 1984) an ADC-to-he-
patocyte differentiation lineage relationship. In addition, more
recent lineage tracing studies have also led to disparate results
(Friedman and Kaestner, 2011). Specifically, Cre-based labeling
using Osteopontin- or Lgr5-inducible drivers resulted in the in-
heritance of label in hepatocytes, although in both cases, the
contribution to the hepatocyte pool was very low (Espan˜ol-Sun˜er
et al., 2012; Huch et al., 2013). More dramatic evidence for liver
progenitors was provided by Furuyama et al. (2011), who re-
ported that a significant percentage (up to 90%) of the liver
was eventually marked following pulse labeling with a Sox9-
CreER strain, a result that, on face value, is strong evidence for
physiologically active stem cells. By contrast, other studies utiliz-
ing a similar but separately constructed Sox9-CreER strain did
not find evidence for such liver progenitors (Carpentier et al.,
2011; Tarlow et al., 2014). Additionally, in using a similar hepato-
cyte labeling method with adeno-associated virus, no decrease
in labeling was observed following most forms of injury, and a
scant 1.3% reduction in labeling was observed following CCl4
injury (an effect whose statistical significance from baseline
was not reported), indicating that stem cells play a minor role,
if any, in liver homeostasis and regeneration (Malato et al., 2011).
The ability to reach strong conclusions about lineage is
deeply dependent on the specificity of the tracing tools used.
For example, the OPN-, Lgr5-, and Sox9-based lineage tracing
studies all rely on the assumption that Cre-mediated recombina-
tion never occurs in hepatocytes. If such a lack of specificity
were to exist, even to a small extent, one would be left with the
impression that hepatocytes are derived from BECs or ADCs,
when in fact, no such progenitor-progeny relationship existed.346 Cell Stem Cell 15, 340–349, September 4, 2014 ª2014 Elsevier Inc.We speculate that this technical point ac-
counts for the discrepancy between our
results and those of others who have re-
ported liver progenitor cell activity in vivo.
Indeed, when we tested the specificity of
the same Sox9-CreER strain used by Fur-
uyama and colleagues (Soeda et al.,
2010) with a R26YFP reporter, we found
that this strain confers substantial hepa-tocyte labeling (Figure S4). This result is consistent with the
observation that Sox9 is induced in hepatocytes solely by
tamoxifen administration (Carpentier et al., 2011; Tarlow et al.,
2014) and under pathological conditions (Yanger et al., 2013).
Hence, ‘‘ectopic’’ Sox9 expression in hepatocytes, resulting in
their labeling, may have led to the erroneous conclusion that
they were derived from biliary cells. A similar phenomenon may
have contributed to the low level of hepatocytes marked with
OPN-CreER (Espan˜ol-Sun˜er et al., 2012) and Lgr5-CreER
(Huch et al., 2013), as hepatocytes have a propensity for
expressing certain biliary markers, including osteopontin, on
stress (Coombes and Syn, 2013; Limaye et al., 2008a; Yanger
et al., 2013). As a ‘‘terminal’’ biliary marker, Krt19 appears to
be an exception to this specificity problem; in contrast to Sox9
and OPN, Krt19 is not expressed by hepatocytes on injury,
and hepatocytes become Krt19+ only after prolonged toxin
exposure as part of a hepatocyte-to-BEC reprogramming
process (Yanger et al., 2013). Indeed, we have observed that
OPN is normally expressed in a large subset of hepatocytes
in injured conditions (data not shown). Hence, Krt19-CreER
mice are likely to represent a more specific—and, hence, more
reliable—tool for assessing the contribution of BECs and ADCs
to liver repopulation.
Our results do not eliminate the possibility that, under more
demanding circumstances, ADCs could exhibit bipotency. For
instance, in lower vertebrates such as zebrafish, >95% hepato-
cyte ablation in young fish results in a BEC contribution to hepa-
tocyte differentiation, a phenomenon that also occurs to a lesser
extent in adult fish (Choi et al., 2014; He et al., 2014). However, in
FAH/-deficient mice that exhibit gross hepatocyte death, he-
patocyte transplantation rescues and repopulates the liver while
the ADC-containing population does not (Tarlow et al., 2014).
Similarly, we cannot rule out the possibility that the Krt19-CreER
strain, which labeled 30%–40% of biliary cells, failed to mark a
Figure 5. TA Cells Do Not Give Rise to
Hepatocytes
(A) Representative image of dual-labeled cells,
obtained by liver biopsy following the ‘‘pulse.’’
(B) Schematic view of the double-label pulse-
chase experiment and the possible outcomes
(see Results). d, days.
(C) Top panels: representative immunofluorescent
images of labeled cells in livers from ‘‘pulse’’ (left)
and ‘‘chase’’ (right) mice following treatment with a
CDE diet. Middle panels: high magnification view
of the areas indicated in the top panels. Bottom
panel: quantification of single- and dual-labeled
hepatocytes (Hep) and ADCs following pulse or
chase (R6 2003 fields counted per mouse, n = 6).
(D) Top panels: representative immunofluorescent
images of labeled cells in livers from ‘‘pulse’’ (left)
and ‘‘chase’’ (right) mice following treatment
with DDC. Middle panels: high-magnification view
of the areas indicated in the top panels. Bottom
panel: quantification of single- and double-labeled
hepatocytes (Hep) and ADCs following pulse or
chase (R6 2003 fields counted per mouse, n = 7).
Arrows denote single-labeled ADCs; arrow-
heads denote double-labeled ADCs; the asterisk
indicates a single-labeled hepatocyte; and the
plus sign indicates a double labeled hepatocyte.
PanCK, pancytokeratin; Scale bars, 50 mm. See
also Figure S3.
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Liver Regeneration Does Not Utilize Stem Cellssubset of ADCs with progenitor activity. However, a comparison
of the biliary cells labeled by this strain to those cells that
remained unmarked failed to reveal any differences between
the two populations (with respect to markers or proliferation).
In addition, the two independent lineage tracing approaches
we used—hepatocyte labeling and dual-nucleoside labeling—
further bolsters the interpretation that biliary cells do not
contribute to hepatocyte neogenesis, at least in the injurymodels
we examined.
Likewise, it remains possible that hepatocytes differ with
respect to replicative ability or that a specialized subset of hepa-
tocytes remains multipotent. Hepatocyte heterogeneity with
respect to cell division has been recently reported (Miyaoka
et al., 2012) although whether this reflects an intrinsic property
of a subset of hepatocytes or simply stochastic differences has
yet to be determined. In either case, our data support the view
that new adult hepatocytes come from preexisting hepatocytes,
not only following partial hepatectomy but also in the setting of
toxin injuries as well. As hepatocytes are able to divide more
than 100 times without losing function (Overturf et al., 1997)
and can also differentiate into biliary cells on injury (Yanger
et al., 2013; Tanimizu et al., 2014; Sekiya and Suzuki, 2014),
hepatocytes rather than biliary cells would appear to constitute
the facultative stem cell compartment of the liver.Cell Stem Cell 15, 340–349, SEXPERIMENTAL PROCEDURES
Mice and Injury
Mice were maintained in a pathogen-free environ-
ment. Krt19-CreER andRosaYFP strains have been
described elsewhere (Means et al., 2008; Srinivas
et al., 2001). To generate an ADC response, 6- to
8-week-old mice were given 0.1% wt/wt DDC(Sigma-Aldrich) in PMI Mouse Diet #5015 (Harlan Teklad) for 2–3 weeks, at
which point the diet was changed to regular chow for 3–5 weeks to allow
mice to recover. A choline-deficient diet (MP Biomedicals) supplemented
with 0.15% ethionine drinking water (Sigma-Aldrich, E5139) was administered
for 2 weeks as described elsewhere (Carpentier et al., 2011), followed by
2 weeks of recovery. Mice were fed 0.25 g/kg of chow supplemented with
ANIT (Dyets) as described elsewhere (Faa et al., 1998) for 2 weeks, followed
by the same length of recovery. CCl4 administration and recovery was con-
ducted as described elsewhere using the chronic injury protocol of Malato
et al. (2011). Partial hepatectomy was performed as described elsewhere
(Greenbaum et al., 1995), followed by a 2-week recovery period. As expected,
we observed the emergence of numerous ADCs within 2 weeks of DDC, ANIT,
and CCl4 treatment and within 4 days of CDE treatment.
Viral Infections and Tamoxifen Administration
Pulse labeling with AAV8-TBG-Cre virus was performed as described else-
where in 6- to 8-week-old mice, followed by a 2-week washout period (Yanger
et al., 2013). KRT19-CreER transgenes were achieved by giving mice 40 mg of
tamoxifen over five doses. For labeling ADCs, KRT19-CreER; R26YFP mice
were given three to five doses of tamoxifen (8 mg per dose) during the second
half of DDC and CDE treatments. All studies were conducted in accordance
with the policies of the National Institutes of Health and the University of Penn-
sylvania Institutional Animal Care and Use Committee guidelines.
Nucleoside Analog-Based Pulse-Chase Double Labeling
Six-week-oldmalemice (C57BL/6J, Harlan) were fed a CDE diet for twoweeks
or a DDC diet for three weeks. Following the aforementioned period, 1 mg/mleptember 4, 2014 ª2014 Elsevier Inc. 347
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Liver Regeneration Does Not Utilize Stem CellsIdU (Sigma-Aldrich) was added to drinking water for 4 days. Following a
washout period of 4 days, 1 mg/ml CldU (MP Biomedicals) was added to
drinking water for 4 days. After another 2 days, mice were anesthetized, and
one omental lobe was removed via laparotomy (Greene and Puder, 2003) for
further analysis. For examining pulse-chase labeling after a ‘‘recovery period’’
(Figure S3F), mice were fed normal chow for another 4 weeks before sacrifice.
For labeling experiments involving DDC treatment, DDC administration was
performed as described earlier. Liver and small intestine tissue sections
were triple stained with anti-bromodeoxyuridine antibodies as described
elsewhere with minor modifications (Teta et al., 2007) and with anti-Pancyto-
keratin (DAKO). Every staining included mice that received only one of the
thymidine analogs. Images were obtained with an inverted confocal micro-
scope (Olympus). Cells were counted manually in a blinded fashion using
ImageJ software (R6 3 200 fields).
Immunostaining and Quantification
Antibody staining was performed as described elsewhere (Zong et al., 2009).
Primary antibody sources and concentrations are listed in Table S1. The
percentage of marker-positive cells was determined by taking representative
images and directly counting cell number. For all quantitations, cell enumera-
tions for each experiment are listed in the text or figure legends. Student’s
t tests were used to calculate p values. Error bars show SD.
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